Clinical Trials on Refractory Brain Tumors
Total 47382 results
-
University Hospital, GhentUniversity GhentRecruiting
-
University Hospital, GhentResearch Foundation FlandersCompletedEpilepsyBelgium, United States
-
Wake Forest University Health SciencesTerminatedEpilepsy | Refractory EpilepsyUnited States
-
University of ArkansasCompletedEpilepsyUnited States
-
University Hospital, GhentMedtronicCompletedRefractory Epilepsy
-
MedtronicNeuroCompletedRefractory EpilepsyBelgium, Sweden, Austria, United Kingdom, Poland, Germany, Portugal, Canada, Finland, Hungary, Italy, Netherlands, Russian Federation
-
Assiut UniversityUnknown
-
University of PaviaUniversity of Bologna; University of CatanzaroCompleted
-
Beijing Pins Medical Co., LtdUnknown
-
University of California, DavisTerminated
-
St. Joseph's Hospital and Medical Center, PhoenixH. Lundbeck A/SUnknownRefractory EpilepsyUnited States
-
Providence Health & ServicesAduro Biotech, Inc.CompletedBrain Tumor | Glioblastoma Multiforme | Anaplastic Astrocytoma | Astrocytic TumorsUnited States
-
St. Jude Children's Research HospitalRecruitingBrain and Central Nervous System TumorsUnited States
-
MapKure, LLCRecruitingSolid Tumor | B-Raf Mutation-Related TumorsUnited States, Australia
-
Fujian Cosunter Pharmaceutical Co. LtdUnknownSolid Tumor | C-Met Mutation-Related TumorsChina
-
Keystone Nano, IncNational Cancer Institute (NCI); National Institutes of Health (NIH)UnknownCarcinoma | Cancer | Solid Tumors | TumorUnited States
-
Centre Francois BaclesseActive, not recruitingProton Therapy | Benign Brain TumorsFrance
-
Masonic Cancer Center, University of MinnesotaCompletedGlioblastoma | Brain Tumor | Ependymoma | Medulloblastoma | Anaplastic AstrocytomaUnited States
-
Hellenic Cooperative Oncology GroupCompletedBreast Tumors | Brain Metastases | Lung TumorsGreece
-
Ontario Clinical Oncology Group (OCOG)Ontario Cancer Research NetworkCompletedVenous Thromboembolism | Brain TumorsUnited States, Canada
-
Michael Vogelbaum, MD, PhDNational Cancer Institute (NCI)TerminatedAdult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Recurrent Adult Brain TumorUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingRecurrent Neuroblastoma | Refractory Neuroblastoma | High Risk NeuroblastomaUnited States, Canada, Puerto Rico, Australia, New Zealand
-
Children's Cancer and Leukaemia GroupCompletedBrain and Central Nervous System TumorsUnited Kingdom, Ireland
-
Blueprint Medicines CorporationCompletedGastrointestinal Stromal Tumors (GIST) | Other Relapsed or Refractory Solid TumorsUnited States, United Kingdom, France, Korea, Republic of, Belgium, Germany, Italy, Netherlands, Poland, Spain
-
St. Jude Children's Research HospitalRecruitingHepatocellular Carcinoma | Pediatric Cancer | Malignant Solid Tumor | Fibrolamellar Carcinoma | Pediatric Solid Tumor | Refractory Solid TumorUnited States
-
National Institute on Drug Dependence, ChinaPeking University; Shengjing HospitalRecruiting
-
McGill UniversityRecruiting
-
Beijing Tiantan HospitalPeking Union Medical College Hospital; Chinese PLA General Hospital; Xuanwu Hospital... and other collaboratorsUnknown
-
Mossakowski Medical Research Centre Polish Academy...Institute of Mother and Child, Warsaw, PolandCompletedRefractory Epilepsy
-
Lady Hardinge Medical CollegeCompletedRefractory EpilepsyIndia
-
Mid-Atlantic Epilepsy and Sleep Center, LLCUnknown
-
University College London HospitalsTerminated
-
Beijing Pins Medical Co., LtdBeijing Tiantan HospitalUnknownRefractory EpilepsyChina
-
Hospices Civils de LyonCompleted
-
All India Institute of Medical Sciences, New DelhiCompleted
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedBrain Tumor | Metastatic Melanoma | Brain Metastases | Glioma of BrainUnited States
-
Immatics US, Inc.CompletedCancer | Solid Tumor, Adult | Refractory Cancer | Recurrent CancerUnited States, Germany
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)CompletedSarcoma | Kidney Cancer | Unspecified Childhood Solid Tumor, Protocol Specific | Leukemia | Ovarian Cancer | Brain and Central Nervous System Tumors | Neuroblastoma | Liver Cancer | Extragonadal Germ Cell Tumor | Childhood Germ Cell TumorUnited States
-
The Cleveland ClinicNational Cancer Institute (NCI)CompletedBrain Tumor | Central Nervous System TumorsUnited States
-
Children's Cancer and Leukaemia GroupCompletedSarcoma | Unspecified Childhood Solid Tumor, Protocol Specific | Brain and Central Nervous System TumorsUnited Kingdom, Ireland
-
Dana-Farber Cancer InstituteCompletedCarcinoid Tumor | Pancreatic Neuroendocrine TumorUnited States
-
Lund University HospitalCompleted
-
Florida International UniversityNational Institute on Minority Health and Health Disparities (NIMHD); Nicklaus... and other collaboratorsRecruitingRecurrent Childhood Ependymoma | Recurrent Childhood Acute Lymphoblastic Leukemia | Recurrent Childhood Acute Myeloid Leukemia | Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Recurrent Childhood Rhabdomyosarcoma | Recurrent Childhood Soft Tissue Sarcoma | Recurrent Childhood Large... and other conditionsUnited States
-
University of NebraskaRecruitingPrimary Brain Tumor | Metastatic Brain TumorUnited States
-
Hospices Civils de LyonCompletedPosterior Brain Fossa Tumors in ChildrenFrance
-
Amsterdam UMC, location VUmcRecruitingGlioblastoma | Glioblastoma Multiforme | GBM | Glioblastoma, Adult | Recurrent Brain TumorNetherlands
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Agenus Inc.TerminatedGliosarcoma | Recurrent Glioblastoma | Recurrent Adult Brain TumorUnited States
-
University of Erlangen-Nürnberg Medical SchoolNot yet recruitingBrain Tumor, Primary | Brain Tumor - MetastaticGermany
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Melanoma | Clinical Stage IV Cutaneous Melanoma AJCC v8 | Pathologic Stage IV Cutaneous Melanoma AJCC v8 | Metastatic Malignant Neoplasm in the Brain | Refractory Melanoma | BRAF V600 Wild Type | Intracranial MelanomaUnited States
-
National Cancer Institute (NCI)RecruitingRecurrent WHO Grade 2 Glioma | Recurrent Low Grade Astrocytoma | Refractory Low Grade Astrocytoma | Refractory Low Grade Glioma | Refractory WHO Grade 1 GliomaUnited States, Canada